Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -72.12% is 40% above its 1-year average of -120.85%, near the high end of its 1-year range (-147.74%–-72.12%).
As of the fiscal period ended Tuesday, June 30, 2026. 40.32% above its 12-month average of -120.85%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -72.12%.
RETURN ON INVESTED CAPITAL (ROIC)
-72.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-120.85%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+40.32%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 825 covered companies
CURRENT VS SECTOR MEDIAN
-102.24%
vs the sector median at left
Filana Therapeutics, Inc.
Market Cap
$40.48M
Return on Invested Capital (ROIC)
-72.12%
TTM Avg
-120.85%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$41.09M
Return on Invested Capital (ROIC)
-60.64%
TTM Avg
-93.35%
3Y Avg
-138.83%
5Y Avg
-96.86%
Market Cap
$39.15M
Return on Invested Capital (ROIC)
-66.03%
TTM Avg
-39.70%
3Y Avg
-29.53%
5Y Avg
-27.72%
Market Cap
$41.92M
Return on Invested Capital (ROIC)
-8.43%
TTM Avg
-19.61%
3Y Avg
-40.73%
5Y Avg
-42.38%
Market Cap
$38.92M
Return on Invested Capital (ROIC)
1.99%
TTM Avg
-3.38%
3Y Avg
-2.67%
5Y Avg
-1.50%
Market Cap
$43.22M
Return on Invested Capital (ROIC)
-80.92%
TTM Avg
33.73%
3Y Avg
-139.74%
5Y Avg
-139.74%
Market Cap
$37.83M
Return on Invested Capital (ROIC)
-32.18%
TTM Avg
-103.25%
3Y Avg
-133.41%
5Y Avg
-116.42%
Market Cap
$43.38M
Return on Invested Capital (ROIC)
2.80%
TTM Avg
30.48%
3Y Avg
30.48%
5Y Avg
-223.44%
Market Cap
$43.59M
Return on Invested Capital (ROIC)
-127.36%
TTM Avg
-34.70%
3Y Avg
-36.91%
5Y Avg
-31.07%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | $40.48M | -72.12% | -120.85% | N/A | N/A |
| Veru Inc. (VERU)vs › | $41.09M | -60.64% | -93.35% | -138.83% | -96.86% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.15M | -66.03% | -39.70% | -29.53% | -27.72% |
| Precipio, Inc. (PRPO)vs › | $41.92M | -8.43% | -19.61% | -40.73% | -42.38% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.92M | 1.99% | -3.38% | -2.67% | -1.50% |
| BioStem Technologies, Inc. (BSEM)vs › | $43.22M | -80.92% | 33.73% | -139.74% | -139.74% |
| Incannex Healthcare Limited (IXHL)vs › | $37.83M | -32.18% | -103.25% | -133.41% | -116.42% |
| SANUWAVE Health Inc. (SNWV)vs › | $43.38M | 2.80% | 30.48% | 30.48% | -223.44% |
| Nano-X Imaging Ltd. (NNOX)vs › | $43.59M | -127.36% | -34.70% | -36.91% | -31.07% |
| Edesa Biotech, Inc. (EDSA)vs › | $36.94M | -166.02% | -208.81% | -185.70% | -165.34% |
ROIC
-72.1%
ROE
-66.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -72.12% |
| 2026-03-31 | -120.10% |
| 2025-12-31 | -128.00% |
| 2025-09-30 | -136.28% |
| 2025-06-30 | -147.74% |
